Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant

Microbes and Infection

Volumn 13, Issue 4, 2011, Pages 359-368

  Briggs, Caitlin M ^a   Holder, Robert C ^a   Reid, Sean D ^a   Parks, Griffith D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Macrophage; Parainfluenza virus

Indexed keywords

BETA INTERFERON; INTERFERON; INTERFERON INDUCING AGENT; VIRUS VECTOR;

ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE DERIVED MACROPHAGE; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS 5; PARAINFLUENZA VIRUS INFECTION; PRIORITY JOURNAL; RNA VIRUS; SIGNAL TRANSDUCTION; STREPTOCOCCUS PYOGENES; UPREGULATION; VIRUS ATTENUATION; VIRUS CULTURE; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALS; CERCOPITHECUS AETHIOPS; GENE EXPRESSION REGULATION, VIRAL; GRAM-POSITIVE BACTERIA; HUMANS; INTERFERON-BETA; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MACROPHAGE ACTIVATION; MACROPHAGES; MUTATION; RESPIROVIRUS; RESPIROVIRUS INFECTIONS; SIGNAL TRANSDUCTION; VERO CELLS; VIRUS REPLICATION;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES; PARAINFLUENZA VIRUS; POSIBACTERIA; RNA VIRUSES; STREPTOCOCCUS PYOGENES;

EID: 79952444358     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.12.005     Document Type: Article

References (47)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
2. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
3. Biron C.A. Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr. Opin. Microbiol. 1999, 2:374-381.
4. Kim H.M., Lee Y.W., Lee K.J., Kim H.S., Cho S.W., van Rooijen N., Guan Y., Seo S.H. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J. Virol. 2008, 82:4265-4274.
5. Wijburg O.L., DiNatale S., Vadolas J., Van Rooijen N., Strugnell R.A. Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection. J. Virol. 1997, 71:9450-9457.
6. Kumagai Y., Takeuchi O., Kato H., Kumar H., Matsui K., Morii E., Aozasa K., Kawai T., Akira S. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 2007, 27:240-252.
7. Akira S., Takeda K. Toll-like receptor signaling. Nat. Rev. Immunol. 2004, 7:499-511.
8. Liew F.Y., Damo X., Brint E.K., O'Neill L.A.J. Negative regulation of TLR-mediated immune responses. Nat. Rev. Immunol. 2005, 5:446-458.
9. Salek-Ardakani S., Lyons S.A., Arrand J.R. Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-alpha. J. Immunol. 2004, 173:321-331.
10. Bartz H., Buning-Pfaue F., Turkel O., Schauer U. Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin. Exp. Immunol. 2002, 129:438-445.
11. Muthumani K., Hwang D.S., Choo A.Y., Mayilvahanan S., Dayes N.S., Thieu K.P., Weiner D.B. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int. Immunol. 2005, 17:103-116.
12. Wunschmann S., Becker B., Vallbracht A. Hepatitis A virus suppresses monocyte-to-macrophage maturation in vitro. J. Virol. 2002, 76:4350-4356.
13. Frascaroli G., Varani S., Blankenhorn N., Pretsch R., Bacher M., Leng L., Bucala R., Landini M.P., Mertens T. Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J. Immunol. 2009, 182:477-488.
14. Nguyen D.T., de Witte L., Ludlow M., Yuksel S., Wiesmuller K.H., Geijtenbeee T.B.H., Osterhaus A.D.M., de Swart R.L. Synthetic bacterial lipopeptide Pam3CSK4 modulates RSV infection independent of TLR activation. PLoS Pathog. 2010, 6:e1001049.
15. Thibault S., Fromentin R., Tardif M.R., Trembley M.J. TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells. Retrovirology 2009, 6:42.
16. Bafica A., Scanga C.A., Equils O., Sher A. The induction of Toll-like receptor tolerance enhances rather than suppresses HIV-1 gene expression in transgenic mice. J. Leukoc. Biol. 2004, 75:460-466.
17. Zhang J., Li G., Bafica A., Pantelic M., Zhang P., Brozmeyer H., Liu Y., Wetzler L., He J.J., Chen T. Niesseria gonorrhoeae enhances infection of dendritic cells by HIV type I. J. Immunol. 2005, 174:7995-8002.
18. Arimilli S., Alexander-Miller M.A., Parks G.D. A Simian Virus 5 (SV5) mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function. J. Virol. 2006, 80:3416-3427.
19. Lamb R.A., Parks G.D. Fields Virology 2007, 1449-1496. Lippincott Williams and Wilkins Publishers, Philadelphia, PA. fifth ed. B. Fields, D. Knipe, P. Howley (Eds.).
20. Didcock L., Young D.F., Goodbourn S., Randall R.E. The V protein of simian virus 5 inhibits interferon signaling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 1999, 73:9928-9933.
21. Andrejeva J., Childs K.S., Young D.F., Carlos R.S., Stock N., Goodbourn S., Randall R.E. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. 2004, 101:17264-17269.
22. Wansley E.K., Parks G.D. Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and induces cell death. J. Virol. 2002, 76:10109-10121.
23. Capraro G.A., Johnson J.J., Kock N.D., Parks G.D. Growth and antibody responses to respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus simian virus 5. Virology 2008, 376:416-428.
24. Gainey M.D., Manuse M.J., Parks G.D. A hyperfusogenic F protein enhances the oncolytic potency of an SV5 P/V mutant without compromising sensitivity to type I interferon. J. Virol. 2008, 82:9369-9380.
25. Pejawar-Gaddy S., Gitiban-Vaghefi N., Parks G.D., Alexander-Miller M.A. Distinct pathways for signaling maturation in macrophages and dendritic cells infected with paramyxovirus simian virus 5. Viral Immunol. 2007, 20:76-87.
26. Pannetier D., Faure C., Georges-Courbot M.C., Deubel V., Baize S. Human macrophages, but not dendritic cells, are activated and produce interferons in response to Mopeia virus infection. J. Virol. 2004, 78:10516-10524.
27. Wansley E.K., Dillon P.J., Gainey M.D., Tam J., Cramer S.D., Parks G.D. Growth sensitivity of a recombinant simian virus P/V mutant to type I IFN differs between tumor cell lines and normal primary cells. Virology 2005, 335:131-144.
28. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2009, 8:533-544.
29. Sing A., Merlin T., Knopf J.P., Nilsen P.J., Loppnow H., Galanos C., Freudenberg M.A. Bacterial induction of beta interferon in mice is a function of the LPS component. Infect. Immun. 2000, 68:1600-1607.
30. Falk L.A., Vogel S.N. Differential production of IFN-alpha/beta by CSF-1 and GM-CSF-derived macrophages. J. Leuk. Biol. 1990, 48:43-49.
31. Kobayashi K., Hernandez L.D., Galán J.E., Janeway C.A., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002, 110:191-202.
32. Wilden H., Fournier P., Zawatzky R., Schirrmacher V. Expression of RIG-I, IRF-3, IFN-beta and IRF-7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus. Int. J. Oncol. 2009, 34:971-982.
33. Carlos T.S., Fearns R., Randall R.E. Interferon-induced alterations in the pattern of parainfluenza virus 5 transcription and protein synthesis and the induction of virus inclusion bodies. J. Virol. 2005, 79:14112-14121.
34. de Jong M.A., de Witte L., Oudhoff M.J., Gringhuis S.I., Gallay P., Geijtenbeek T.B. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human langerhans cells ex vivo. J. Clin. Invest. 2008, 118:3440-3452.
35. Zhang H., Niesel D.W., Peterson J.W., Klimpel G.R. Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect. Immun. 1998, 66:5196-5201.
36. Hu X., Chakravarty S.D., Ivashkiv L.B. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 2008, 226:41-56.
37. Wang J., Hu Y., Deng W.W., Sun B. Negative regulation of Toll-like receptor signaling pathway. Microbes Infect. 2009, 11:321-327.
38. Nakayama K., Okugawa S., Yanagimoto S., Kitazawa T., Tsukada K., Kawada M., Kimura S., Hirai K., Takagaki Y., Ota Y. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J. Biol. Chem. 2004, 279:6629-6634.
39. Hedl M., Li J., Cho J.H., Abraham C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. 2007, 104:19440-19445.
40. Wesche H., Gao X., Li X., Kirschning C.J., Stark G.R., Cao Z. IRAK-M is a novel member of the Pelle/Interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 1999, 27:19403-19410.
41. Sabbah A., Chang T.H., Harnack R., Frohlich V., Tominaga K., Dube P.H., Xiang Y., Bose S. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 2009, 10:1073-1080.
42. Manuse M.J., Parks G.D. Role for the Paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing. J. Virol. 2009, 83:9057-9067.
43. Hou J., Wang P., Lin L., Liu X., Ma F., An H., Wang Z., Cao X. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting Traf6, IRAK1, and IRAK2. J. Immunol. 2009, 83:2150-2158.
44. Von Messling V., Cattaneo R. Toward novel vaccines and therapies based on negative strand RNA viruses. Curr. Top. Microbiol. Immunol. 2004, 283:281-312.
45. Lehtinen P., Jaritti T., Virkki R., Vuorinen T., Leinonen M., Peltola V., Ruohola A., Ruuskanen O. Bacterial coinfections in children with viral wheezing. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:463-469.
46. Roberts A.L., Connolly K.L., Doern C.D., Holder R.C., Reid S.D. Loss of the group A Streptococcus regulator Srv decreases biofilm formation in vivo in an otitis media model of infection. Infect. and Immun. 2010, 78:4800-4808.
47. Parsonage D., Newton G.L., Holder R.C., Wallace B.D., Paige C., Hamilton C.J., Dos Santos P.C., Redinbo M.R., Reid S.D., Claiborne A. Characterization of the N-acetyl-alpha-d-glucosaminyl l-malate synthase and deacetylase functions for bacillithiol biosynthesis in bacillus anthracis. Biochemistry 2010, 49:8398-8414.